An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington’s disease patient neurons

An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington’s disease patient neurons

Krach et al. dissect the molecular mechanism of the alternative splicing modulator Branaplam in Huntington’s disease. They show that the drug lowers mutant HTT protein levels and ameliorates alternative splicing pathology in an iPSC disease model.

Bibliographic Details
Main Authors:	Florian Krach, Judith Stemick, Tom Boerstler, Alexander Weiss, Ioannis Lingos, Stephanie Reischl, Holger Meixner, Sonja Ploetz, Michaela Farrell, Ute Hehr, Zacharias Kohl, Beate Winner, Juergen Winkler
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-022-34419-x

Similar Items

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
by: Andreas Neueder, et al.
Published: (2017-05-01)

Impaired adult olfactory bulb neurogenesis in the R6/2 mouse model of Huntington's disease
by: Kohl Zacharias, et al.
Published: (2010-09-01)

Intracellular A53T Mutant α-Synuclein Impairs Adult Hippocampal Newborn Neuron Integration
by: Martin Regensburger, et al.
Published: (2020-11-01)

Parkinsonism with a Hint of Huntington’s from 29 CAG Repeats in HTT
by: Sipilä JOT
Published: (2019-09-01)

Huntington’s Disease—An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components
by: Aleksandra S. Taran, et al.
Published: (2020-06-01)

A novel and accurate full-length HTT mouse model for Huntington’s disease
by: Sushila A Shenoy, et al.
Published: (2022-01-01)

In silico designing of putative peptides for targeting pathological protein Htt in Huntington's disease
by: Harleen Kohli, et al.
Published: (2021-02-01)

Functional Characterisation of the Circular RNA, <i>circHTT(2-6)</i>, in Huntington’s Disease
by: Laura Gantley, et al.
Published: (2023-05-01)

Integrated analysis on transcriptome and behaviors defines HTT repeat-dependent network modules in Huntington's disease
by: Lulin Huang, et al.
Published: (2022-03-01)

Intrastriatal Administration of AAV5-miHTT in Non-Human Primates and Rats Is Well Tolerated and Results in miHTT Transgene Expression in Key Areas of Huntington Disease Pathology
by: Elisabeth A. Spronck, et al.
Published: (2021-01-01)

Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease
by: Bardile, Costanza Ferrari, et al.
Published: (2020)

Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
by: Cesar L. Moreno, et al.
Published: (2016-01-01)

Evidence of Extensive Alternative Splicing in Post Mortem Human Brain HTT Transcription by mRNA Sequencing.
by: Adam T Labadorf, et al.
Published: (2015-01-01)

Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
by: Elsa C. Kuijper, et al.
Published: (2024-01-01)

Atypical course of Parkinson’s disease with clinical manifestations of Huntington’s disease in a patient with an allele of 27 CAG repeats in the HTT gene
by: M. A. Nikitina, et al.
Published: (2021-01-01)

Excess Rab4 rescues synaptic and behavioral dysfunction caused by defective HTT-Rab4 axonal transport in Huntington’s disease
by: Joseph A. White, et al.
Published: (2020-07-01)

AAV5-miHTT Gene Therapy Demonstrates Sustained Huntingtin Lowering and Functional Improvement in Huntington Disease Mouse Models
by: Elisabeth A. Spronck, et al.
Published: (2019-06-01)

Identification of a HTT-specific binding motif in DNAJB1 essential for suppression and disaggregation of HTT
by: S. M. Ayala Mariscal, et al.
Published: (2022-08-01)

Generation of an induced pluripotent stem cell line from a Huntington’s disease patient with a long HTT-PolyQ sequence
by: Duncan C. Miller, et al.
Published: (2023-04-01)

Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's disease.
by: Sydney R Coffey, et al.
Published: (2017-01-01)

Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families
by: Thays A. Apolinário, et al.
Published: (2020-04-01)

Comparison of mHTT Antibodies in Huntington's Disease Mouse Models Reveal Specific Binding Profiles and Steady-State Ubiquitin Levels with Disease Development.
by: Zubeyde Bayram-Weston, et al.
Published: (2016-01-01)

Characterization of HTT inclusion size, location, and timing in the zQ175 mouse model of Huntington's disease: an in vivo high-content imaging study.
by: Nikisha Carty, et al.
Published: (2015-01-01)

Comment on: “Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease‐affected families.”
by: Gustavo L. Franklin, et al.
Published: (2020-06-01)

Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington’s disease
by: Jaisan Islam, et al.
Published: (2021-11-01)

Loss of huntingtin function slows synaptic vesicle endocytosis in striatal neurons from the httQ140/Q140 mouse model of Huntington's disease
by: Robyn L. McAdam, et al.
Published: (2020-02-01)

IN VIVO INTERROGATION OF THE CONTRIBUTION OF SPECIFIC SPLICING FACTORS TO PATHOLOGICAL MIS-SPLICING IN HUNTINGTON´S DISEASE
by: David Lozano-Muñoz, et al.
Published: (2023-10-01)

In Vivo Optical Imaging of Neurogenesis: Watching New Neurons in the Intact Brain
by: Sebastien Couillard-Despres, et al.
Published: (2008-01-01)

Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs
by: Huichun Tong, et al.
Published: (2023-10-01)

HTT2 promotes plant thermotolerance in Brassica rapa
by: Jianxia Jiang, et al.
Published: (2018-06-01)

Axon-Specific Mitochondrial Pathology in SPG11 Alpha Motor Neurons
by: Fabian Güner, et al.
Published: (2021-07-01)

TAF1 SPLICING VARIANTS AND PROLYL HYDROXYLASE INHIBITORS IN HUNTINGTON’S DISEASE
by: Claudia Rodríguez-López, et al.
Published: (2023-10-01)

C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice
by: Michaela K. Back, et al.
Published: (2021-11-01)

The personality trait openness is related to cerebral 5-HTT levels.
by: Kalbitzer, J, et al.
Published: (2009)

Loss aversion and 5HTT gene variants in adolescent anxiety
by: Monique Ernst, et al.
Published: (2014-04-01)

Rolling Bearing Fault Diagnosis Based on an Improved HTT Transform
by: Bin Pang, et al.
Published: (2018-04-01)

Association analysis of Epworth Sleepiness Scale (ESS) scores with serotonin transporter (5-HTT- LPR, 5-HTT-VNTR) and circadian (PER3-VNTR) genes
by: Filiz Ozen, et al.

Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models
by: Anja Schulze-Krebs, et al.
Published: (2021-08-01)